Coronavirus: UAE to offer third dose to recipients of China’s Sinopharm vaccine
- The United Arab Emirates appears to be the first country worldwide to formally introduce such booster shots
- The move comes amid concerns about an insufficient antibody response and questions over the vaccine’s efficacy
The brief statement comes after some residents in the UAE reported receiving a third shot amid concerns about an insufficient antibody response. China’s top disease control official acknowledged last month that the country’s locally produced vaccines offer low protection against the virus, adding to growing questions over the shot’s efficacy.
The Sinopharm vaccine has become the linchpin of the UAE’s vaccination campaign, among the fastest in the world per capita.
The country, home to the oil-rich capital Abu Dhabi and glitzy city state Dubai, has raced to widespread immunity in hopes of a swift economic reopening. Dubai draws heavily from the service-heavy tourism and aviation industries, which have been clobbered by the coronavirus.
01:21
UAE is first government to officially approve Chinese coronavirus vaccine developed by Sinopharm
Aside from efficacy numbers, the Chinese manufacturer has released very little public data about its Sinopharm vaccine, prompting criticism for its lack of transparency. Nonetheless, the shot is at the heart of China’s own mass immunisation campaign and its vast vaccine diplomacy efforts.
The World Health Organization granted the Sinopharm shot emergency approval earlier this month, potentially paving the way for millions of doses to reach needy countries through the UN-backed Covax Facility vaccine programme. A range of governments, including in Hungary, Pakistan, Serbia and the Seychelles, an island nation in the Indian Ocean, already administer Sinopharm.
This spring, the UAE became the first in the world to manufacture its own local version of the Sinopharm vaccine. Widespread vaccination also plays a key role in preparing Dubai to host the long-awaited World Expo in October this year, expected to draw some 25 million visitors.
“As part of the state’s proactive strategy to provide maximum protection for society, the door has been opened for the public to receive an additional supportive dose of the Sinopharm vaccine for people,” said Dr Farida al-Hosani, an Emirati health spokeswoman, in a statement broadcast on state television.
WHO’s Sinopharm approval opens the door for China’s vaccine industry
The government statement did not reveal any further information, saying only that all approved vaccines undergo strict safety tests. In the first public release of information on the shot’s efficacy last year, the UAE said the vaccine was 86 per cent effective against the virus based on its review of an interim analysis, without providing further details.
In March, an official from a state-linked Emirati company distributing Sinopharm set off a storm of confusion when he acknowledged on Dubai’s state-owned radio that “a very small number” of residents had already received booster shots of Sinopharm.
At first, Abu Dhabi exclusively used Sinopharm for its roll-out, while the neighbouring emirate of Dubai offered other options, including Pfizer-BioNTech and Oxford-AstraZeneca. However, in recent weeks, Abu Dhabi has started to offer Pfizer as well.
Across the country, most low-paid workers from Africa, Southeast Asia and the Middle East who power the UAE’s economy received the Sinopharm vaccine.
00:49
Philippine President Duterte receives first dose of China's Sinopharm Covid -19 vaccine
Infections in the UAE have gradually declined from peaks reached in January as tourists fleeing lockdowns back home flooded the country’s bars and beaches. But daily counts of new cases still hover over 1,000 a day, far above last year’s levels, even as the country has administered 117 vaccine doses per 100 residents.
Unlike other countries with rapid vaccination drives, like Israel and Britain, the UAE remained open for business after emerging from a strict lockdown a year ago.
Earlier this month, health authorities in Bahrain, another small Gulf Arab sheikhdom that has relied on Sinopharm for its speedy campaign, reported that a booster shot “will soon be made available to individuals, with the aim of strengthening herd immunity”.
Hours after the Emirati announcement Tuesday, Bahrain issued a similar statement saying that it, too, will begin offering a booster vaccine to Sinopharm recipients. It said the third shot would initially go to a prioritised group, including first responders, residents over 50 and those with underlying health conditions.
